MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 01, 2022 for Shree Kishoriju Trading & Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - We Are Pleased To Inform That The Board Of Directors Of The Company, In Their Meeting Held Today I.E., Thursday, May 26, 2022 Has Inter-Alia Transacted The Following Business: The Audited Financial Results (Standalone) For The Quarter And Financial Year Ended March 31, 2022 Pursuant To Regulation 33 Of The SEBI LODR Regulations. (A Copy Of The Said Results, Notes Thereto And Auditor'S Report Is Annexed Hereto And Marked As Annexure I.)
we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business: The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.) MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, May 26, 2022
we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business:The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexures) MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2022 ('The Financial Results');
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 ,inter alia, to consider and approve The Audited Financial Results of the Company for the quarter and year ended March 31, 2022 ('the Financial Results'); MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 18, 2022 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company MANGALAM DRUGS & ORGANICS LTD. 2 CIN NO. L24230MH1972PLC116413 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2021-22,2022-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21,2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-JAYANT BARDEDesignation :-COMPANY SECRETARY Name of the Chief Financial Officer :- AJAY SAMANT Designation : -CHIEF FINANCIAL OFFICER Date: 13/05/2022 MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 05, 2022 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMANGALAM DRUGS & ORGANICS LTD. 2CINL24230MH1972PLC116413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 19.73 4Highest Credit Rating during the previous FY INDBBB 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: JAYANT BARDE Designation: COMPANY SECRETARY EmailId: investor@mangalamdrugs.com Name of the Chief Financial Officer: AJAY SAMANT Designation: Chief Financial Officer EmailId: contactus@mangalamdrugs.com Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.